Skip to main content
Erschienen in: Allergo Journal 3/2020

08.05.2020 | Allergologie in der HNO-Heilkunde | Original Zur Zeit gratis

Allergen-Immuntherapie in der aktuellen Covid-19-Pandemiea, b, c

verfasst von: Prof. Dr. med. Ludger Klimek, Prof. Dr. med. Oliver Pfaar, Prof. Dr. med. Margitta Worm, Prof. Dr. med. Karl-Christian Bergmann, Prof. Dr. Dr. med. Thomas Bieber, Roland Buhl, Prof. Dr. med. Jeroen Buters, Prof. Dr. med. Ulf Darsow, Thomas Keil, Prof. Dr. med. Jörg Kleine-Tebbe, Prof. Dr. med. Susanne Lau, Prof. Dr. med. Marcus Maurer, Hans Merk, Prof. Dr. med. dDpl.-Ing. Ralph Mösges, Prof. Dr. med. Joachim Saloga, Petra Staubach, Dagmar Poethig, Klaus Rabe, Dr. med. Uta Rabe, Prof. Dr. med. Claus Vogelmeier, Prof. Dr. med. Tilo Biedermann, Priv.-Doz. Dr. med. Kirsten Jung, Wolfgang Schlenter, Prof. Dr. med. Dr. phil. Johannes Ring, Adam Chaker, Prof. Dr. med. Wolfgang Wehrmann, PD Dr. med. Sven Becker, Norbert Mülleneisen, Katja Nemat, Prof. Dr. med. Wolfgang Czech, Holger Wrede, Prof. Dr. med. Randolf Brehler, Prof. Dr. med. Thomas Fuchs, Peter-Valentin Tomazic, Prof. Dr. med. Werner Aberer, Antje Fink-Wagner, Prof. Dr.Dr. med. Friedrich Horak, PD Mag. Dr. Stefan Wöhrl, Verena Niederberger-Leppin, Isabella Pali-Schöll, Wolfgang Pohl, Regina Roller-Wirnsberger, Otto Spranger, Dr. med. Rudolf Valenta, Mübecell Akdis, Cezmi Akdis, Dr. med. Karin Hoffmann-Sommergruber, Marek Jutel, Paolo Matricardi, François Spertini, Nikolai Khaltaev, Jean-Pierre Michel, Laurent Nicod, Prof. Dr. med. Peter Schmid-Grendelmeier, Prof. Dr. med. Eckard Hamelmann, Prof. Dr. med. Thilo Jakob, Prof. Dr. med. Thomas Werfel, Priv.-Doz. Dr. med. Martin Wagenmann, Prof. Dr. med. Christian Taube, Jean Bousquet, Prof. Dr. med. Torsten Zuberbier, Prof. Dr. med. Christian Vogelberg, Michael Gerstlauer

Erschienen in: Allergo Journal | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Auszug

Positionspapier der deutschen ARIA-GruppeA in Kooperation mit der österreichischen ARIA-GruppeB, der schweizerischen ARIA-GruppeC, dem Ärzteverband Deutscher Allergologen (AeDA)D, der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI)E und der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)F in Kooperation mit der AG Klinische Immunologie, Allergologie und Umweltmedizin der DGHNO-KHCG und der Europäischen Akademie für Allergologie und klinische Immunologie (EAACI)H
Literatur
1.
Zurück zum Zitat Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998;102(4 Pt 1):558-62 Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998;102(4 Pt 1):558-62
2.
Zurück zum Zitat Durham SR, Leung DY. One hundred years of allergen immunotherapy: time to ring the changes. J Allergy Clin Immunol, 2011;127:3-7 Durham SR, Leung DY. One hundred years of allergen immunotherapy: time to ring the changes. J Allergy Clin Immunol, 2011;127:3-7
3.
Zurück zum Zitat Jutel M, Van de Veen W, Agache I, Azkur KA, Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development. Allergol Int 2013;62:425-33 Jutel M, Van de Veen W, Agache I, Azkur KA, Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development. Allergol Int 2013;62:425-33
4.
Zurück zum Zitat Dhami S, Kakourou A, Asamoah F, Agache I, Lau S, Jutel M et al. Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis. Allergy 2017;72:1825-48 Dhami S, Kakourou A, Asamoah F, Agache I, Lau S, Jutel M et al. Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis. Allergy 2017;72:1825-48
5.
Zurück zum Zitat Dhami S, Nurmatov U, Arasi S, Khan T, Asaria M, Zaman H et al. Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis. Allergy 2017;72:1597-631 Dhami S, Nurmatov U, Arasi S, Khan T, Asaria M, Zaman H et al. Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis. Allergy 2017;72:1597-631
6.
Zurück zum Zitat Klimek L, Brehler R, Hamelmann E, Kopp M, Ring J, Treudler R et al. CME-Kurs. Entwicklung der subkutanen Allergen- Immuntherapie (Teil 1): von den Anfängen zu immunologisch orientierten Therapiekonzepten. Evolution of subcutaneous allergen immunotherapy (part 1): from first developments to mechanism-driven therapy concepts. Allergo J Int 2019;28:78-95. CME-Fragebogen in Allergo J 2019;28:26-47 Klimek L, Brehler R, Hamelmann E, Kopp M, Ring J, Treudler R et al. CME-Kurs. Entwicklung der subkutanen Allergen- Immuntherapie (Teil 1): von den Anfängen zu immunologisch orientierten Therapiekonzepten. Evolution of subcutaneous allergen immunotherapy (part 1): from first developments to mechanism-driven therapy concepts. Allergo J Int 2019;28:78-95. CME-Fragebogen in Allergo J 2019;28:26-47
7.
Zurück zum Zitat Klimek L, Brehler R, Hamelmann E, Kopp M, Ring J, Treudler R et al. CME-Kurs. Entwicklung der subkutanen Allergen-Immuntherapie (Teil 2): präventive Aspekte der SCIT und Innovationen. / Development of subcutaneous allergen immunotherapy (part 2): preventive aspects and innovations. Allergo J Int 2019;28:107-19. Allergo J 2019; 28:31-45 Klimek L, Brehler R, Hamelmann E, Kopp M, Ring J, Treudler R et al. CME-Kurs. Entwicklung der subkutanen Allergen-Immuntherapie (Teil 2): präventive Aspekte der SCIT und Innovationen. / Development of subcutaneous allergen immunotherapy (part 2): preventive aspects and innovations. Allergo J Int 2019;28:107-19. Allergo J 2019; 28:31-45
8.
Zurück zum Zitat Durham SR, Emminger W, Kapp A, de Monchy JG, Rak S, Scadding GK et al. SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol 2012;129:717-25.e5 Durham SR, Emminger W, Kapp A, de Monchy JG, Rak S, Scadding GK et al. SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol 2012;129:717-25.e5
9.
Zurück zum Zitat Nurmatov U, Dhami S, Arasi S, Roberts G, Pfaar O, Muraro A et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews. Clin Transl Allergy 2017;7:24 Nurmatov U, Dhami S, Arasi S, Roberts G, Pfaar O, Muraro A et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews. Clin Transl Allergy 2017;7:24
10.
Zurück zum Zitat Queisser A, Hagedorn S, Wang H, Schaefer T, Konantz M, Alavi S et al. Ecotropic viral integration site 1, a novel oncogene in prostate cancer. Oncogene 2017;36:1573-84 Queisser A, Hagedorn S, Wang H, Schaefer T, Konantz M, Alavi S et al. Ecotropic viral integration site 1, a novel oncogene in prostate cancer. Oncogene 2017;36:1573-84
11.
Zurück zum Zitat Blumchen K, Trendelenburg V, Ahrens F, Gruebl A, Hamelmann E, Hansen G et al. Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy. J Allergy Clin Immunol Pract 2019;7:479-91.e10. Blumchen K, Trendelenburg V, Ahrens F, Gruebl A, Hamelmann E, Hansen G et al. Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy. J Allergy Clin Immunol Pract 2019;7:479-91.e10.
12.
Zurück zum Zitat Chu DK, Wood RA, French S, Fiocchi A, Jordana M, Waserman S et al. Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety. Lancet 2019;393:2222-32 Chu DK, Wood RA, French S, Fiocchi A, Jordana M, Waserman S et al. Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety. Lancet 2019;393:2222-32
13.
Zurück zum Zitat Dhami S, Zaman H, Varga EM, Sturm GJ, Muraro A, Akdis CA et al. Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis. Allergy 2017;72:342-65 Dhami S, Zaman H, Varga EM, Sturm GJ, Muraro A, Akdis CA et al. Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis. Allergy 2017;72:342-65
14.
Zurück zum Zitat Asaria M, Dhami S, van Ree R, Gerth van Wijk R, Muraro A, Roberts G et al. Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview. Allergy 2018;73:269-83 Asaria M, Dhami S, van Ree R, Gerth van Wijk R, Muraro A, Roberts G et al. Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview. Allergy 2018;73:269-83
15.
Zurück zum Zitat Jutel M, Agache I, Bonini S, Burks AW, Calderon M, Canonica W et al. International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics. J Allergy Clin Immunol 2016;137:358-68 Jutel M, Agache I, Bonini S, Burks AW, Calderon M, Canonica W et al. International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics. J Allergy Clin Immunol 2016;137:358-68
16.
Zurück zum Zitat Meadows A, Kaambwa B, Novielli N, Huissoon A, Fry-Smith A, Meads C et al. A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis. Health Technol Assess 2013;17:vi, xi-xiv, 1-322 Meadows A, Kaambwa B, Novielli N, Huissoon A, Fry-Smith A, Meads C et al. A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis. Health Technol Assess 2013;17:vi, xi-xiv, 1-322
17.
Zurück zum Zitat Woehlk C, von Bülow A, Kriegbaum M, Backer V, Porsbjerg C. Allergic asthma is associated with increased risk of infections requiring antibiotics. Ann Allergy Asthma Immunol 2018;120:169-76.e1 Woehlk C, von Bülow A, Kriegbaum M, Backer V, Porsbjerg C. Allergic asthma is associated with increased risk of infections requiring antibiotics. Ann Allergy Asthma Immunol 2018;120:169-76.e1
18.
Zurück zum Zitat Ahmetaj L, Mehic B, Gojak R, Neziri A. The Effect of Viral Infections and Allergic Inflammation in Asthmatic Patients on Immunotherapy. Turk J Immunol 2018;6:123-30 Ahmetaj L, Mehic B, Gojak R, Neziri A. The Effect of Viral Infections and Allergic Inflammation in Asthmatic Patients on Immunotherapy. Turk J Immunol 2018;6:123-30
19.
Zurück zum Zitat Iemoli E, Borgonovo L, Fusi A, Magni C, Ricci ED, Rizzardini G et al. Sublingual allergen immunotherapy in HIV-positive patients. Allergy 2016;71:412-5 Iemoli E, Borgonovo L, Fusi A, Magni C, Ricci ED, Rizzardini G et al. Sublingual allergen immunotherapy in HIV-positive patients. Allergy 2016;71:412-5
20.
Zurück zum Zitat Reuter S, Lemmermann NAW, Maxeiner J, Podlech J, Beckert H, Freitag K et al. Coincident airway exposure to low-potency allergen and cytomegalovirus sensitizes for allergic airway disease by viral activation of migratory dendritic cells. PLoS Pathog 2019;15:e1007595 Reuter S, Lemmermann NAW, Maxeiner J, Podlech J, Beckert H, Freitag K et al. Coincident airway exposure to low-potency allergen and cytomegalovirus sensitizes for allergic airway disease by viral activation of migratory dendritic cells. PLoS Pathog 2019;15:e1007595
21.
Zurück zum Zitat Klimek L, Kündig T, Kramer MF, Guethoff S, Jensen-Jarolim E, Schmidt-Weber CB et al. Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases. Allergo J Int 2018;27:245-55 Klimek L, Kündig T, Kramer MF, Guethoff S, Jensen-Jarolim E, Schmidt-Weber CB et al. Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases. Allergo J Int 2018;27:245-55
22.
Zurück zum Zitat Storni F, Zeltins A, Balke I, Heath MD, Kramer MF, Skinner MA et al. Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens. J Allergy Clin Immunol, 2020;145:1240-53.e3 Storni F, Zeltins A, Balke I, Heath MD, Kramer MF, Skinner MA et al. Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens. J Allergy Clin Immunol, 2020;145:1240-53.e3
23.
Zurück zum Zitat Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med 2020;382:1199-207 Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med 2020;382:1199-207
24.
Zurück zum Zitat Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al.; China Novel Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020;382:727-33 Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al.; China Novel Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020;382:727-33
25.
Zurück zum Zitat Gorbalenya A, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA et al.; Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536-44 Gorbalenya A, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA et al.; Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536-44
26.
Zurück zum Zitat Zhang JJ, Dong X, Cao YY, Yuan YD, Yang B, Yan YQ et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020. doi: 10.1111/all.14238 Zhang JJ, Dong X, Cao YY, Yuan YD, Yang B, Yan YQ et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020. doi: 10.1111/all.14238
27.
Zurück zum Zitat Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol 2020;92:418-23 Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol 2020;92:418-23
28.
Zurück zum Zitat Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506 Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506
29.
Zurück zum Zitat World Health Organization, W.H. 2020; www.who.int World Health Organization, W.H. 2020; www.who.int
30.
Zurück zum Zitat Zhou F, Yu T, Du R Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62 Zhou F, Yu T, Du R Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62
31.
Zurück zum Zitat European Centre for Disease Prevention and Control. Rapid risk assessment: Novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK - sixth update - 12 March 2020. [URL: https://www.ecdc.europa.eu/sites/default/files/documents/RRA-sixth-update-Outbreak-of-novel-coronavirus-disease-2019-COVID-19.pdf; abgerufen am 06.04.2020] European Centre for Disease Prevention and Control. Rapid risk assessment: Novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK - sixth update - 12 March 2020. [URL: https://​www.​ecdc.​europa.​eu/​sites/​default/​files/​documents/​RRA-sixth-update-Outbreak-of-novel-coronavirus-disease-2019-COVID-19.​pdf; abgerufen am 06.04.2020]
32.
Zurück zum Zitat World Health Organization (WHO). Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) - 28 February 2020. [URL: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf; abgerufen am 06.04.2020] World Health Organization (WHO). Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) - 28 February 2020. [URL: https://​www.​who.​int/​docs/​default-source/​coronaviruse/​who-china-joint-mission-on-covid-19-final-report.​pdf; abgerufen am 06.04.2020]
33.
Zurück zum Zitat Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H et al.; Washington State 2019-nCoV Case Investigation Team. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med 2020;382:929-36 Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H et al.; Washington State 2019-nCoV Case Investigation Team. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med 2020;382:929-36
34.
Zurück zum Zitat Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med 2020;382:970-1 Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med 2020;382:970-1
35.
Zurück zum Zitat Klimek L, Akdis C, Bousquet J, Akdis M, Bachert C, Agache I et al. and ARIA-MASK study group. Handling of Allergen Immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement. Allergy 2020 (in press) Klimek L, Akdis C, Bousquet J, Akdis M, Bachert C, Agache I et al. and ARIA-MASK study group. Handling of Allergen Immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement. Allergy 2020 (in press)
36.
Zurück zum Zitat European Centre for Disease Prevention and Control. COVID-19. 2020, www.ecdc.europa.eu/en/covid-19-pandemic (06.04.2020) European Centre for Disease Prevention and Control. COVID-19. 2020, www.ecdc.europa.eu/en/covid-19-pandemic (06.04.2020)
37.
Zurück zum Zitat World Health Organization (WHO). Coronavirus disease (COVID-19) outbreak. 2020; www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19 (06.04.2020) World Health Organization (WHO). Coronavirus disease (COVID-19) outbreak. 2020; www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19 (06.04.2020)
38.
Zurück zum Zitat Pfaar O, Agache I, de Blay F, Bonini S, Chaker AM, Durham SR et al. Perspectives in allergen immunotherapy: 2019 and beyond. Allergy 2019;74 Suppl 108:3-25 Pfaar O, Agache I, de Blay F, Bonini S, Chaker AM, Durham SR et al. Perspectives in allergen immunotherapy: 2019 and beyond. Allergy 2019;74 Suppl 108:3-25
39.
Zurück zum Zitat Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D et al., Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol 2020. doi: 10.1038/s41423-020-0402-2 Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D et al., Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol 2020. doi: 10.1038/s41423-020-0402-2
40.
Zurück zum Zitat World Health Organization (WHO). Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected - 19 March 2020. [PDF via URL: https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125; abgerufen am 06.04.2020] World Health Organization (WHO). Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected - 19 March 2020. [PDF via URL: https://​www.​who.​int/​publications-detail/​infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125; abgerufen am 06.04.2020]
41.
Zurück zum Zitat World Health Organization (WHO). Infection prevention and control of epidemic- and pandemic prone acute respiratory infections in health care. 2014 [URL: https://apps.who.int/iris/bitstream/handle/10665/112656/9789241507134_eng.pdf;jsessionid=986659FAA71555C68D66B6EE5994E9F0?sequence=1, abgerufen am 06.04.2020] World Health Organization (WHO). Infection prevention and control of epidemic- and pandemic prone acute respiratory infections in health care. 2014 [URL: https://​apps.​who.​int/​iris/​bitstream/​handle/​10665/​112656/​9789241507134_​eng.​pdf;jsessionid=986659FAA71555C68D66B6EE5994E9F0?sequence=1, abgerufen am 06.04.2020]
42.
Zurück zum Zitat European Centre for Disease Prevention and Control. Technical Report: Guidance for wearing and removing personal protective equipment in healthcare settings for the care of patients with suspected or confirmed COVID - 19 February 2020. [URL: https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-guidance-wearing-and-removing-personal-protective-equipment-healthcare-settings-updated.pdf; abgerufen am 06.04.2020] European Centre for Disease Prevention and Control. Technical Report: Guidance for wearing and removing personal protective equipment in healthcare settings for the care of patients with suspected or confirmed COVID - 19 February 2020. [URL: https://​www.​ecdc.​europa.​eu/​sites/​default/​files/​documents/​COVID-19-guidance-wearing-and-removing-personal-protective-equipment-healthcare-settings-updated.​pdf; abgerufen am 06.04.2020]
43.
Zurück zum Zitat World Health Organization (WHO). Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19) - 27 February 2020. [URL: https://apps.who.int/iris/bitstream/handle/10665/331215/WHO-2019-nCov-IPCPPE_use-2020.1-eng.pdf; abgerufen am 06.04.2020] World Health Organization (WHO). Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19) - 27 February 2020. [URL: https://​apps.​who.​int/​iris/​bitstream/​handle/​10665/​331215/​WHO-2019-nCov-IPCPPE_​use-2020.​1-eng.​pdf; abgerufen am 06.04.2020]
Metadaten
Titel
Allergen-Immuntherapie in der aktuellen Covid-19-Pandemiea, b, c
verfasst von
Prof. Dr. med. Ludger Klimek
Prof. Dr. med. Oliver Pfaar
Prof. Dr. med. Margitta Worm
Prof. Dr. med. Karl-Christian Bergmann
Prof. Dr. Dr. med. Thomas Bieber
Roland Buhl
Prof. Dr. med. Jeroen Buters
Prof. Dr. med. Ulf Darsow
Thomas Keil
Prof. Dr. med. Jörg Kleine-Tebbe
Prof. Dr. med. Susanne Lau
Prof. Dr. med. Marcus Maurer
Hans Merk
Prof. Dr. med. dDpl.-Ing. Ralph Mösges
Prof. Dr. med. Joachim Saloga
Petra Staubach
Dagmar Poethig
Klaus Rabe
Dr. med. Uta Rabe
Prof. Dr. med. Claus Vogelmeier
Prof. Dr. med. Tilo Biedermann
Priv.-Doz. Dr. med. Kirsten Jung
Wolfgang Schlenter
Prof. Dr. med. Dr. phil. Johannes Ring
Adam Chaker
Prof. Dr. med. Wolfgang Wehrmann
PD Dr. med. Sven Becker
Norbert Mülleneisen
Katja Nemat
Prof. Dr. med. Wolfgang Czech
Holger Wrede
Prof. Dr. med. Randolf Brehler
Prof. Dr. med. Thomas Fuchs
Peter-Valentin Tomazic
Prof. Dr. med. Werner Aberer
Antje Fink-Wagner
Prof. Dr.Dr. med. Friedrich Horak
PD Mag. Dr. Stefan Wöhrl
Verena Niederberger-Leppin
Isabella Pali-Schöll
Wolfgang Pohl
Regina Roller-Wirnsberger
Otto Spranger
Dr. med. Rudolf Valenta
Mübecell Akdis
Cezmi Akdis
Dr. med. Karin Hoffmann-Sommergruber
Marek Jutel
Paolo Matricardi
François Spertini
Nikolai Khaltaev
Jean-Pierre Michel
Laurent Nicod
Prof. Dr. med. Peter Schmid-Grendelmeier
Prof. Dr. med. Eckard Hamelmann
Prof. Dr. med. Thilo Jakob
Prof. Dr. med. Thomas Werfel
Priv.-Doz. Dr. med. Martin Wagenmann
Prof. Dr. med. Christian Taube
Jean Bousquet
Prof. Dr. med. Torsten Zuberbier
Prof. Dr. med. Christian Vogelberg
Michael Gerstlauer
Publikationsdatum
08.05.2020
Verlag
Springer Medizin
Erschienen in
Allergo Journal / Ausgabe 3/2020
Print ISSN: 0941-8849
Elektronische ISSN: 2195-6405
DOI
https://doi.org/10.1007/s15007-020-2539-9

Weitere Artikel der Ausgabe 3/2020

Allergo Journal 3/2020 Zur Ausgabe

Pharmaforum

Pharmaforum

AeDA/DGAKI informieren

Berufsdermatosen: ein Überblick

AeDA/DGAKI informieren

Biologika und Covid-19

Das könnte Sie auch interessieren

08.05.2020 | Asthma bronchiale | AeDA/DGAKI informieren Zur Zeit gratis

Glukokortikoide und COVID-19

15.06.2020 | Telemedizin | Titel Zur Zeit gratis

COVID-19: Biologika bei allergischen und Typ-2-entzündlichen Erkrankungen weiter anwenden?

Positionspapier des Ärzteverbands Deutscher Allergologen (AeDA)A, der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI)B, der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI)D, der Luxemburgischen Gesellschaft für Allergologie und Immunologie (LGAI)E, der Österreichischen Gesellschaft für Pneumologie (ÖGP)F in Kooperation mit der deutschen, österreichischen, und schweizerischen ARIA-GruppeG und der Europäischen Akademie für Allergologie und Klinische Immunologie (EAACI)H

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.